Company / Operating Cash Flow
Q32 Bio Inc. Operating Cash Flow History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$67.7M
FY2025
5-year range
-$113.7M / -$18.7M
FY2021-FY2025
Trend
-262.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow changed -263% YoY in FY2025, a notable deviation from the 7-year average annual change of -153%.
Based on SEC 10-K filings.
-$68M in FY2025.
Improved from -$114M to -$68M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow decreased 262.6% year-over-year.
- Peak operating cash flow was recorded in FY2018.
- Lowest operating cash flow in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$67.7M | -262.6% |
| FY2024 | -$18.7M | +83.6% |
| FY2023 | -$113.7M | -3.6% |
| FY2022 | -$109.8M | -16.3% |
| FY2021 | -$94.3M | -3.3% |
| FY2020 | -$91.4M | -114.6% |
| FY2019 | -$42.6M | -756.9% |
| FY2018 | $6.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026